These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37077930)

  • 1. A Physician's Guide to the Use of Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms.
    Marks E; Jarell A; Ludzik J; Farberg AS; Rabinovitz HS; Phelps RG; Cockerell CJ; Witkowski A
    J Clin Aesthet Dermatol; 2023 Apr; 16(4):12-20. PubMed ID: 37077930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management.
    Witkowski A; Jarell AD; Ahmed KL; Siegel JJ; Russell BH; Rogers JH; Goldberg MS; Fernandes NF; Ludzik J; Farberg AS
    Melanoma Manag; 2024; 11(1):MMT68. PubMed ID: 38812731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of reflectance confocal microscopy and gene expression profiling for melanocytic lesions with uncertain malignant potential: A case series.
    Gronbeck C; Rabinovitz H; Np MO; Grant-Kels JM
    J Cutan Pathol; 2023 Jul; 50(7):623-628. PubMed ID: 36944578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of the 23-gene expression profile test for an atypical intradermal melanocytic proliferation.
    Marks E; Badia AA; Goldberg MS
    Per Med; 2024 Jan; 21(1):21-27. PubMed ID: 38059357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
    Kashani-Sabet M; Leachman SA; Stein JA; Arbiser JL; Berry EG; Celebi JT; Curiel-Lewandrowski C; Ferris LK; Grant-Kels JM; Grossman D; Kulkarni RP; Marchetti MA; Nelson KC; Polsky D; Seiverling EV; Swetter SM; Tsao H; Verdieck-Devlaeminck A; Wei ML; Bar A; Bartlett EK; Bolognia JL; Bowles TL; Cha KB; Chu EY; Hartman RI; Hawryluk EB; Jampel RM; Karapetyan L; Kheterpal M; Lawson DH; Leming PD; Liebman TN; Ming ME; Sahni D; Savory SA; Shaikh SS; Sober AJ; Sondak VK; Spaccarelli N; Usatine RP; Venna S; Kirkwood JM
    JAMA Dermatol; 2023 May; 159(5):545-553. PubMed ID: 36920356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real world validation of an adjunctive gene expression-profiling assay for melanoma diagnosis and correlation with clinical outcomes at an academic center.
    Boothby-Shoemaker W; Guan L; Jones B; Chaffins M; Kohen L; Pimentel J; Veenstra J; Friedman BJ
    Hum Pathol; 2023 Sep; 139():73-79. PubMed ID: 37423481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difficulty in interpreting gene expression profiling in BAP-negative melanocytic tumors.
    Fischer AS; High WA
    J Cutan Pathol; 2018 May; ():. PubMed ID: 29752733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of Dermoscopy and 31-Gene Expression Profiling by Dermatology Providers in Melanoma Management Care.
    Witkowski A; Lee C; Latour E; Vetto J; Ludzik J
    J Drugs Dermatol; 2022 Dec; 21(12):1347-1352. PubMed ID: 36468965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
    North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
    Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test.
    Mirsky R; Prado G; Svoboda R; Glazer A; Rigel D
    J Drugs Dermatol; 2018 Nov; 17(11):1220-1223. PubMed ID: 30500144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
    Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
    JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Prior Diagnoses on Dermatopathologists' Interpretations of Melanocytic Lesions: A Randomized Controlled Trial.
    Elmore JG; Eguchi MM; Barnhill RL; Reisch LM; Elder DE; Piepkorn MW; Brunyé TT; Radick AC; Shucard HL; Knezevich SR; Kerr KF
    JAMA Dermatol; 2022 Sep; 158(9):1040-1047. PubMed ID: 35947391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teledermatology for diagnosing skin cancer in adults.
    Chuchu N; Dinnes J; Takwoingi Y; Matin RN; Bayliss SE; Davenport C; Moreau JF; Bassett O; Godfrey K; O'Sullivan C; Walter FM; Motley R; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013193. PubMed ID: 30521686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility and Micro-Costing Framework for
    Barrutia L; Schuuring E; Rácz E; Diercks GFH; van Kempen LC
    Diagnostics (Basel); 2024 Aug; 14(15):. PubMed ID: 39125541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
    Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
    J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
    Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD
    Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management Decisions.
    Farberg AS; Glazer AM; White R; Rigel DS
    J Drugs Dermatol; 2017 May; 16(5):428-431. PubMed ID: 28628677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.